Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gwinn

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Clinical Neuropharmacology|February 27, 1999
A pilot study on the motor effects of rimantadine in Parkinson's diseaseV G Evidente, C H Adler, J N Caviness, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Risperidone is effective in severe hemichorea/hemiballismusV G Evidente, K Gwinn-Hardy, J N Caviness, et al.
Lancet (London, England)|June 8, 1999
L-dopa slows the progression of familial parkinsonismK Gwinn-Hardy, V G Evidente, C Waters, et al.
Neurology|November 9, 2005
Challenges and opportunities in clinical trials for spinal muscular atrophyD Hirtz, S Iannaccone, J Heemskerk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Amantadine is beneficial in restless legs syndromeV G Evidente, C H Adler, J N Caviness, et al.
Neurology|January 31, 2007
How common are the "common" neurologic disorders?D Hirtz, D J Thurman, K Gwinn-Hardy, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|December 29, 2000
The effect of temperature on hand function in patients with tremorC Cooper, V G Evidente, J G Hentz, et al.
Inorganic Chemistry|April 12, 2024
Synthesis, Characterization, and the Effect of Lewis Bases on the Nuclearity of Iron Alkoxide ComplexesReilly K Gwinn, Matthew Williams, Trevor P Latendresse, et al.
Neurology|May 26, 2004
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplicationD W Miller, S M Hague, J Clarimon, et al.
Neuroreport|April 15, 1999
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's diseaseS Lincoln, J Vaughan, N Wood, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Clinical Neuropharmacology|February 27, 1999
A pilot study on the motor effects of rimantadine in Parkinson's diseaseV G Evidente, C H Adler, J N Caviness, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Risperidone is effective in severe hemichorea/hemiballismusV G Evidente, K Gwinn-Hardy, J N Caviness, et al.
Lancet (London, England)|June 8, 1999
L-dopa slows the progression of familial parkinsonismK Gwinn-Hardy, V G Evidente, C Waters, et al.
Neurology|November 9, 2005
Challenges and opportunities in clinical trials for spinal muscular atrophyD Hirtz, S Iannaccone, J Heemskerk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Amantadine is beneficial in restless legs syndromeV G Evidente, C H Adler, J N Caviness, et al.
Neurology|January 31, 2007
How common are the "common" neurologic disorders?D Hirtz, D J Thurman, K Gwinn-Hardy, et al.
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|December 29, 2000
The effect of temperature on hand function in patients with tremorC Cooper, V G Evidente, J G Hentz, et al.
Inorganic Chemistry|April 12, 2024
Synthesis, Characterization, and the Effect of Lewis Bases on the Nuclearity of Iron Alkoxide ComplexesReilly K Gwinn, Matthew Williams, Trevor P Latendresse, et al.
Neurology|May 26, 2004
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplicationD W Miller, S M Hague, J Clarimon, et al.
Neuroreport|April 15, 1999
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's diseaseS Lincoln, J Vaughan, N Wood, et al.
Pageof 5